ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1169

Obstetrical Complications in Women with Juvenile Idiopathic Arthritis

Evelyne Vinet1, Sasha Bernatsky2, Mohammed Kaouache2, Christian A. Pineau3, Ann E. Clarke4, Elizabeth Hazel5, Ciaran M. Duffy6, Anick Bérard7 and Debbie Ehrmann Feldman8, 1McGill University Health Center, Montreal, QC, Canada, 2Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 3Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 4Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, 5Rhematology, McGill University Health Centre, Montreal, QC, Canada, 6Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 7Université de Montréal, Montréal, QC, Canada, 8Rehabilitation, Université de Montréal, Montreal, QC, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Juvenile idiopathic arthritis (JIA) and pregnancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic arthritis (JIA) most often affects women before childbearing age. Patients with JIA and their parents often ask about the potential impact of the disease on future pregnancies. Little is known about the risk of obstetrical complications in women with JIA. In a large population-based study, we aimed to determine if women with JIA have an increased risk of obstetrical complications compared to women without JIA.  

Methods: We identified all women who had a hospitalization for their first delivery after JIA diagnosis using Quebec’s physician billing and hospitalization databases (1996-2008). Women were defined as JIA cases if they had ≥ 1 hospitalization with the International Classification of Diseases, Ninth Revision(ICD-9) code 714, as a primary or secondary diagnosis, or ≥ 2 physician visits with the ICD-9 code 714, occurring 2 months to 2 years apart, both prior to the age of 18 years and prior to the delivery. We randomly selected a general population control group, composed of women with their first delivery and matched at least 3:1 for age and year of delivery, without a preceding diagnosis of JIA.

We ascertained the length of hospitalization for delivery, the occurrence of gestational diabetes, premature rupture of membranes (PROM), preeclampsia/eclampsia, and caesarean section (c-section), at the time of hospitalization for delivery, based on relevant diagnostic or procedures codes.  

Results: We identified 1406 women with JIA. Of these women, 90 had their first delivery after JIA diagnosis, during database follow-up, and were matched to 448 controls. Mean age at JIA diagnosis was 15.3 years (95% CI 14.8, 15.8) and mean age at delivery was 22.9 years (95% CI 22.3, 23.5). There was no difference in the length of hospitalization for delivery between women with JIA and controls [3.2 days (95% CI 2.9, 3.5) vs 2.8 days (95% CI 2.7, 3.0)]. Compared to controls, women with JIA did not experience more gestational diabetes [1.1% (95% CI 0.1, 6.9) vs 1.1% (95% CI 0.4, 2.7)], PROM [8.9% (95% CI 4.2, 17.3) vs 8.3% (95% CI 6.0, 11.3)], preeclampsia/eclampsia [3.3% (95% CI 0.9, 10.1) vs 4.7% (95% CI 3.0, 7.2)], or c-section [20.0% (95% CI 12.6, 30.0) vs 20.5% (95% CI 17.0, 24.6)].

Conclusion: Our findings suggest that women with JIA do not seem to have an increased risk of obstetrical complications compared to the general population. We are currently expanding this study by performing mother-child linkage to further assess neonatal outcomes in children born to women with JIA and their controls.


Disclosure:

E. Vinet,
None;

S. Bernatsky,
None;

M. Kaouache,
None;

C. A. Pineau,
None;

A. E. Clarke,
None;

E. Hazel,
None;

C. M. Duffy,
None;

A. Bérard,
None;

D. E. Feldman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obstetrical-complications-in-women-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology